Ipenoxazone is a glutamate receptor antagonist potentially for the treatment of Alzheimer's disease. References: Inoue S, Yamanaka T, Okamoto H, Hosoi H. Effect of a glutamate blocker, ipenoxazone hydrochloride on the hypoxia-induced firing in the medial vestibular nucleus. Acta Otolaryngol Suppl. 2004 Aug;(553):58-60. PubMed PMID: 15277038.

纯度：≥98%

CAS：104454-71-9